InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: None

Thursday, 05/14/2015 8:44:49 AM

Thursday, May 14, 2015 8:44:49 AM

Post# of 346000
Remarkable 2nd ln NSCLC ad by Boeringer Ingelheim!

While Opdivo non-squamous NSCLC results are out, while PPHM 2nd ln NSCLC results (even the 60%, not even the 113%) are out this BI guy says we haven't seen much progress since Docetaxel.

2nd ln NSCLC no progress since DOCETAXEL

Now WHY would BI have an AD (because I got this link via IHub adds that appeared) in which they SELL nothing, say NOTHING about themselves,and just tell us: Hey guys, there is not been much progress in 2nd ln NSCLC since Docetaxel. And for the rest, well the weather is fine here too!

Can anybody offer an explanation UNLESS the next ad is going to be: Breakthrough in 2nd ln NSCLC!

We know about Opdivo, KeyTruda coming soon, and many failed clinical trial for 2nd ln NSCLC. So they cannot be the surprise, if any surprise follow-up ad is coming.

I'd like to understand! And as you see there is a FULL pages of those. Why place them as ADVERTISING NOW? They were recorded 5 months ago!

And BI has one about the IMPORTANCE of PS!!! in 2nd ln NSCLC
You'd think they have a drug themselves.

They are really in the topic

Another : Nothing new in 2nd ln NSCLC and OS

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News